Intensive Insulin Treatment and Ischemic Foot Ulcer
Intensified Insulin Treatment and Skin Microcirculation; Its Relation to Ischemic Foot Ulcer in Patients With Type 1 Diabetes Mellitus: A Long-term Follow-up Study
1 other identifier
interventional
91
1 country
2
Brief Summary
We aim to investigate the relationship between skin microvascular function and the first hospitalization for ischemic foot ulcer in patients with type 1 diabetes former randomized during 7.5 years to intensified conventional insulin treatment (ICT) compared to standard insulin treatment (ST).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jan 1984
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 1984
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedFirst Submitted
Initial submission to the registry
October 4, 2013
CompletedFirst Posted
Study publicly available on registry
October 8, 2013
CompletedResults Posted
Study results publicly available
December 21, 2015
CompletedSeptember 29, 2020
September 1, 2020
27.9 years
October 4, 2013
November 16, 2015
September 28, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Ischemic Foot Ulcer
The study outcome is the first hospitalization for ischemic foot ulcer, defined by the ICD-10 discharge code
Until hospitalization for ischemic foot ulcer or until 31 December 2011
Other Outcomes (1)
Microvascular Endothelial Function
7 years
Study Arms (3)
Intensified insulin treatment
EXPERIMENTALBasal (Monotard) insulin; ones a day Bolus (Actrapid) insulin; thrice a day
Standard treatment
ACTIVE COMPARATORMixed Insulin (2-3 times a day)
Healthy controls
NO INTERVENTIONThese people were solely controls for the iontophoresis method used in the study. With no intervention or follow-up-
Interventions
The treatment regimen of the intensified treatment group consisted of individual education and then continuous tutoring with frequent face-to-face and telephone contact.
Patients continuing with routine diabetes care (insulin treatment), visiting physician every four months
Eligibility Criteria
You may qualify if:
- Born 1930 or later, Type 1 diabetes appearing at age 30 or earlier and with insulin dependency within 1 year from diagnosis, no known abuse of alcohol or drugs, non-prolipherative retinopathy of any degree present, no previous photocoagulation, normal serum creatinine, unsatsifactory blood glucose control according to the physician in charge of the patients.
You may not qualify if:
- Any history or ongoing ischemic foot ulcer,or peripheral artery disease,or osteoartropathy.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Karolinska Institutet, Department of Clinical Science and Education, Södersjukhuset
Stockholm, 118 83, Sweden
Karolinska Institutet, Division of Internal Medicine Södersjukhuset AB
Stockholm, 118 83, Sweden
Related Publications (3)
Reichard P, Britz A, Cars I, Nilsson BY, Sobocinsky-Olsson B, Rosenqvist U. The Stockholm Diabetes Intervention Study (SDIS): 18 months' results. Acta Med Scand. 1988;224(2):115-22. doi: 10.1111/j.0954-6820.1988.tb16748.x.
PMID: 3048052BACKGROUNDReichard P, Nilsson BY, Rosenqvist U. The effect of long-term intensified insulin treatment on the development of microvascular complications of diabetes mellitus. N Engl J Med. 1993 Jul 29;329(5):304-9. doi: 10.1056/NEJM199307293290502.
PMID: 8147960BACKGROUNDRathsman B, Jensen-Urstad K, Nystrom T. Intensified insulin treatment is associated with improvement in skin microcirculation and ischaemic foot ulcer in patients with type 1 diabetes mellitus: a long-term follow-up study. Diabetologia. 2014 Aug;57(8):1703-10. doi: 10.1007/s00125-014-3248-2. Epub 2014 May 7.
PMID: 24802206DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Thomas Nyström
- Organization
- Karolinska Institutet Södersjukhuset
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas Nyström, MD
Karolinska Institutet
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD, PhD
Study Record Dates
First Submitted
October 4, 2013
First Posted
October 8, 2013
Study Start
January 1, 1984
Primary Completion
December 1, 2011
Study Completion
June 1, 2013
Last Updated
September 29, 2020
Results First Posted
December 21, 2015
Record last verified: 2020-09
Data Sharing
- IPD Sharing
- Will not share